KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Assets Average: 2009-2024

Historic Assets Average for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to $41.4 billion.

  • Teva Pharmaceutical Industries' Assets Average fell 3.74% to $40.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $40.0 billion, marking a year-over-year decrease of 3.74%. This contributed to the annual value of $41.4 billion for FY2024, which is 5.35% down from last year.
  • Latest data reveals that Teva Pharmaceutical Industries reported Assets Average of $41.4 billion as of FY2024, which was down 5.35% from $43.7 billion recorded in FY2023.
  • In the past 5 years, Teva Pharmaceutical Industries' Assets Average ranged from a high of $54.1 billion in FY2020 and a low of $41.4 billion during FY2024.
  • Over the past 3 years, Teva Pharmaceutical Industries' median Assets Average value was $43.7 billion (recorded in 2023), while the average stood at $43.7 billion.
  • Data for Teva Pharmaceutical Industries' Assets Average shows a maximum YoY fell of 9.07% (in 2021) over the last 5 years.
  • Teva Pharmaceutical Industries' Assets Average (Yearly) stood at $54.1 billion in 2020, then decreased by 9.07% to $49.2 billion in 2021, then dropped by 6.74% to $45.8 billion in 2022, then decreased by 4.57% to $43.7 billion in 2023, then declined by 5.35% to $41.4 billion in 2024.